Glaxosmithkline In Court Again Over Drug Controversy

Interesting to see Britain’s largest drug manufacturer hitting the headlines for all the wrong reasons again today this time for an indiscretion concerning vaccine trials. Glaxosmithkline and two affiliated scientists have been fined the equivalent of 150000pounds by a court in Argentina for failing to seek proper consent from parents before injecting a vaccine into children.
15000 babies in Argentina and 9000 in Columbia and Panama were involved in a trial known as ‘Compas’. The drugs giant has been accused of preying on the poorest in society in Argentina many of whom are illiterate and possibly didn’t understand the risks involved.

Glaxosmithkline Act Immorally In Drugs Trial

Shockingly while the scientists were paid for each family they cajoled into participating the families themselves did not receive a single peso. The clinical trials continue after the firm implements a corrective action plan designed to ensure families are informed of all the details of the experiment.
Express Solicitors are no strangers to Glaxosmithkline having taken on the firm by representing several individuals who were prescribed the dangerous diabetes drug Avandia. The drug which has been linked to strokes heart attacks and was the subject of a BBC Panorama documentary entitled A Risk Worth Taking? 

Glaxosmithkline Subject Of BBC Documentary Into Dangerous Diabetes Drug Avandia

Following its broadcast we were inundated by individuals who believed their health complications could have been caused by taking this drug. Shockingly in some cases it was prescribed two months after the advice to remove it.
Fortunately Avandia remains banned. If you or a member of your family has suffered a stroke heart failure or heart related death please contact us today to discuss your claim with a specialist Clinical Negligence Solicitor.
Share Button

Leave a Reply

Your email address will not be published.